ranimustine has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, S; Fujitake, H; Hirata, M; Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Ohkubo, A; Okamoto, Y; Takubo, T; Taniguchi, N; Tsubaki, K; Tsubakio, T; Yasunaga, K; Yonezawa, T | 1 |
| Ikeda, Y; Kobayashi, M; Kobayashi, T; Ohno, R; Ohta, K; Shirakawa, S; Tanaka, I; Yamada, H; Yamada, K; Yamagata, K | 1 |
2 other study(ies) available for ranimustine and Thrombopenia
| Article | Year |
|---|---|
[Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Administration, Oral; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Humans; Leukopenia; Nausea; Neoplasms; Nitrosourea Compounds; Tablets; Thrombocytopenia | 1983 |
[Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia Vera; Stomach Neoplasms; Thrombocytopenia | 1985 |